14-day Premium Trial Subscription Try For FreeTry Free
The Joint's (JYNT) expansionary move is expected to be a prudent one, given the growing demand for affordable and convenient chiropractic care in the region.
The Joint Corp. (OTCQB:JSDA) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CF
SCOTTSDALE, Ariz., Oct. 20, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will re
SCOTTSDALE, Ariz., Oct. 20, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will rep
The Joint Corp. is the largest provider of chiropractic care in the U.S., and its stock provides great upside potentials from secular healthcare trends. The company is a value compounder with signific
Although US stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
Although US stocks traded mostly lower on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view th

The Joint Corp. to Participate in Lake Street's 2022 BIG6 Conference

11:05am, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
SCOTTSDALE, Ariz., Sept. 06, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced management is scheduled to attend
The Joint Corp. (NASDAQ:JYNT ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief Executive Off

4 Analysts Have This to Say About Joint

07:18pm, Friday, 05'th Aug 2022 Benzinga
Joint (NASDAQ:JYNT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0 0 2 0 Last 30D 2 0 0

Humana (HUM) Beats Q2 Earnings and Revenue Estimates

11:55am, Wednesday, 27'th Jul 2022 Zacks Investment Research
Humana (HUM) delivered earnings and revenue surprises of 13.04% and 1.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SCOTTSDALE, Ariz., July 21, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will re
SCOTTSDALE, Ariz., July 21, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will rep

Strength Seen in Humana (HUM): Can Its 3.2% Jump Turn into More Strength?

01:51pm, Monday, 18'th Jul 2022 Zacks Investment Research
Humana (HUM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Got $1,000? Buy This Hot Growth Stock Before It Takes Off

12:05pm, Thursday, 30'th Jun 2022 The Motley Fool
Shares of small-cap healthcare company The Joint Corp. have been crushed. Did this create a nice buying opportunity?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE